Other Titles

Promoting mental health globally

Abstract

Session presented on Monday, July 27, 2015:

Bipolar disorder (BPD) is a chronic mental health illness that impacts all aspects of an individual's life and ability to function. The World Health Organization ranks BPD as one of the top ten causes of disability in the world with an incidence as high as 5% in the U.S. The 2000 National Depressive and Manic-Depressive Association Survey of individuals with BPD reported that 69% of patients received an initial misdiagnosis, and 33% had a delay in receiving a correct diagnosis of 10 years. It is fatal when untreated in a high proportion of patients and marks BPD as a major unsolved public health problem. BPDs are known to be missed, misdiagnosed or not treated appropriately in a majority of individuals. Research has shown that screening for BPD in patients with known depression can identify BPD early, thereby reducing the long lag time to diagnosis and treatment. The hypothesis of this study is that the long lag time to diagnosis and treatment of BPD could be reduced if Advanced Practice Registered Nurses (APRN screen patients with a diagnosis of depression using validated screening tools.) This mixed methods descriptive study is the first to explore APRN knowledge of BPD and their perceptions of facilitators and barriers to screening patients with known depression for BPD. Triangulated data from the quantitative and qualitative studies generated a rich description of APRN knowledge, experiences and perceptions of barriers and facilitators to screening for BPDs in their practice. The results of the quantitative study (N=89) found 83.1% (n=74) of the APRN saw patients with a diagnosis of depression, and 55.1% (n=49) did not screen for BPDs. The focus group interviews supported the quantitative results; and highlight that nurses need more education on BPDs. Implementing screening practices for all patients with a known diagnosis of depression can have a direct impact on reducing the morbidity and mortality of undiagnosed BPDs. The results of this study can inform APRNractice, education, 'research and policy.' This includes advocating for full practice authority; policy changes at local, state, and national levels to include screening, research to determine the impact of screening, early treatment and referral; innovations to create and promote collaborative programs that connect individuals with BPD to PCPs and psychiatric care (PMH-NPs) and includes real-time screening at home or in PCP office waiting areas.

Author Details

Ann Marie Kriebel-Gasparro, RN

Sigma Membership

Nu Eta

Type

Presentation

Format Type

Text-based Document

Study Design/Type

Descriptive/Correlational

Research Approach

Mixed/Multi Method Research

Keywords:

Bipolar Disorder, Mixed Methods

Conference Name

26th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

San Juan, Puerto Rico

Conference Year

2015

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Share

COinS
 

Exploration of the impact of screening on the outcomes of bipolar disorders: A mixed methods study

San Juan, Puerto Rico

Session presented on Monday, July 27, 2015:

Bipolar disorder (BPD) is a chronic mental health illness that impacts all aspects of an individual's life and ability to function. The World Health Organization ranks BPD as one of the top ten causes of disability in the world with an incidence as high as 5% in the U.S. The 2000 National Depressive and Manic-Depressive Association Survey of individuals with BPD reported that 69% of patients received an initial misdiagnosis, and 33% had a delay in receiving a correct diagnosis of 10 years. It is fatal when untreated in a high proportion of patients and marks BPD as a major unsolved public health problem. BPDs are known to be missed, misdiagnosed or not treated appropriately in a majority of individuals. Research has shown that screening for BPD in patients with known depression can identify BPD early, thereby reducing the long lag time to diagnosis and treatment. The hypothesis of this study is that the long lag time to diagnosis and treatment of BPD could be reduced if Advanced Practice Registered Nurses (APRN screen patients with a diagnosis of depression using validated screening tools.) This mixed methods descriptive study is the first to explore APRN knowledge of BPD and their perceptions of facilitators and barriers to screening patients with known depression for BPD. Triangulated data from the quantitative and qualitative studies generated a rich description of APRN knowledge, experiences and perceptions of barriers and facilitators to screening for BPDs in their practice. The results of the quantitative study (N=89) found 83.1% (n=74) of the APRN saw patients with a diagnosis of depression, and 55.1% (n=49) did not screen for BPDs. The focus group interviews supported the quantitative results; and highlight that nurses need more education on BPDs. Implementing screening practices for all patients with a known diagnosis of depression can have a direct impact on reducing the morbidity and mortality of undiagnosed BPDs. The results of this study can inform APRNractice, education, 'research and policy.' This includes advocating for full practice authority; policy changes at local, state, and national levels to include screening, research to determine the impact of screening, early treatment and referral; innovations to create and promote collaborative programs that connect individuals with BPD to PCPs and psychiatric care (PMH-NPs) and includes real-time screening at home or in PCP office waiting areas.